4.4 Statewide Protocols, Standing Orders & Naloxone Dispensing

4.4 Statewide Protocols, Standing Orders & Naloxone Dispensing

Over the past decade, the Commonwealth of Virginia has dramatically expanded the role of community pharmacists as public health access points. Through two primary legal instruments—the State Health Commissioner Standing Order for Opioid Antagonists (Va. Code § 54.1-3408(X)) and Board of Pharmacy Statewide Protocols (Va. Code § 54.1-3303.1)—pharmacists are empowered to evaluate patients and dispense critical preventive and therapeutic medications without an individual, patient-specific prescription from an outside prescriber.

Unlike Collaborative Practice Agreements, which require individual practitioner-to-practitioner contracts, Statewide Protocols operate universally across the Commonwealth. Any licensed pharmacist who satisfies the credentialing and protocol criteria may initiate therapy for qualifying patients.

---

Opioid Antagonist Dispensing & The Standing Order (§ 54.1-3408(X))

In response to the nationwide opioid epidemic and the proliferation of illicit synthetic opioids such as fentanyl, Virginia enacted Va. Code § 54.1-3408(X). This statute authorizes the State Health Commissioner to issue a universal standing order authorizing all Virginia-licensed pharmacists to dispense opioid antagonists.

Scope of Dispensing Authority

• Authorized Agents: Intranasal naloxone spray (e.g., Narcan 4 mg, Kloxxado 8 mg), injectable naloxone (intramuscular/subcutaneous with auto-injector or syringe), and intranasal nalmefene (Opvee).
• Eligible Recipients: A pharmacist may dispense an opioid antagonist to any person or entity. This includes:
  • Individuals at risk of experiencing an opioid overdose;
  • Family members, friends, or roommates of individuals at risk;
  • Law enforcement officers, firefighters, emergency medical technicians, and first responders;
  • Public school personnel, university staff, and community services boards (CSBs); and
  • Any concerned citizen who wishes to maintain rescue medication for emergency bystander intervention.
• No Individual Prescription Needed: The medication is billed and dispensed under the State Health Commissioner's standing order (with the Commissioner designated as the prescriber).

Mandatory Overdose Recognition & Administration Counseling

Under Virginia Board guidance and statutory mandates, dispensing an opioid antagonist under the standing order requires providing mandatory patient education and counseling covering five core elements:

1. Overdose Recognition: Pinpoint pupils (miosis), respiratory depression (shallow, irregular, or absent breathing), cyanosis (blue/gray lips and fingernails), limp body, pale/clammy skin, and deep, guttural snoring or gurgling sounds ("death rattle");
2. Call 911 Immediately: The recipient must be emphatically instructed to activate emergency medical services (911) before or immediately after administering the antagonist;
3. Administration Technique: Step-by-step instructions for the specific formulation dispensed (e.g., peel back blister pack, insert nozzle into one nostril, press plunger firmly for nasal spray; or inject firmly into outer thigh for auto-injectors);
4. The Recovery Position: Turning the unresponsive patient onto their side with top knee bent to prevent aspiration of vomitus;
5. The Renarcotization Danger: Naloxone has a relatively short half-life (30 to 90 minutes), whereas many synthetic opioids (e.g., fentanyl, methadone, extended-release oxycodone) remain bound to opioid receptors for many hours. Once naloxone metabolizes, the patient can lapse back into respiratory arrest (renarcotization). A second dose may be administered after 2 to 3 minutes if unresponsiveness persists, and emergency medical evaluation is mandatory even if the patient regains consciousness.

Civil & Criminal Immunity: Under Va. Code § 8.01-225, Virginia's "Good Samaritan" statute provides robust civil and criminal immunity for pharmacists dispensing opioid antagonists in good faith, as well as for lay bystanders administering them in an emergency overdose situation.

---

Virginia Statewide Protocols Under Va. Code § 54.1-3303.1

Under Va. Code § 54.1-3303.1, the Virginia General Assembly authorized the Virginia Board of Pharmacy—in joint consultation with the Board of Medicine and the Virginia Department of Health—to establish standardized clinical protocols. Under these protocols, a licensed pharmacist may initiate treatment and dispense medications directly to patients who meet explicit inclusion criteria.

Authorized Protocol Categories

---

Deep Dive: Hormonal Contraceptive Statewide Protocol

The hormonal contraceptive protocol serves as an exam prototype illustrating the rigorous clinical structure of Virginia statewide protocols.

Clinical Eligibility & Patient Assessment

1. Self-Screening Questionnaire: Prior to dispensing, the patient must complete a standardized Virginia Board-approved health questionnaire based on the CDC U.S. Medical Eligibility Criteria for Contraceptive Use (US MEC).
2. Mandatory Blood Pressure Measurement: Under the protocol, the pharmacist must obtain and document the patient's blood pressure before initiating combined hormonal contraceptives (estrogen-progestin combinations).
   • If blood pressure is elevated (≥ 140/90 mmHg), combined hormonal contraceptives are contraindicated due to stroke and venous thromboembolism (VTE) risks; the patient may only be offered progestin-only pills (or referred to primary care).
3. Absolute Exclusion Criteria (Contraindications):
   • Age ≥ 35 years who currently smoke cigarettes (severe cardiovascular risk);
   • History of deep vein thrombosis (DVT), pulmonary embolism (PE), or known thrombogenic mutations;
   • History of stroke, coronary artery disease, or ischemic heart disease;
   • History of or active breast cancer or other estrogen-dependent neoplasia;
   • Migraine headaches with aura (increased ischemic stroke risk); and
   • Active hepatic impairment or severe cirrhosis.

Supply Limitations & Well-Woman Referral

• Under the statewide protocol, the pharmacist may dispense up to a 12-month supply of hormonal contraceptives.
• The pharmacist must provide written documentation advising the patient to schedule an annual preventive well-woman visit (cervical cancer screening, pelvic examination, sexually transmitted infection screening) with a primary care provider or gynecologist.

---

Provider Notification & Recordkeeping Mandates

For every clinical encounter conducted under Va. Code § 54.1-3303.1, the dispensing pharmacist must satisfy two critical administrative requirements:

1. Primary Care Provider (PCP) Notification

• Timeline: The pharmacist must provide written notification of the medication initiation and clinical assessment findings to the patient's primary care provider within five (5) business days of dispensing.
• Unassigned Patients: If the patient does not have an identified primary care provider, the pharmacist must provide a written copy of the assessment and consultation record directly to the patient, along with educational material emphasizing the importance of establishing regular primary medical care.

2. Record Retention Window

• All patient self-screening questionnaires, clinical assessment notes, blood pressure logs, laboratory screenings, dispensing records, and proof of provider notifications must be preserved in the pharmacy files for a minimum of two (2) years from the date of the clinical encounter.